Page last updated: 2024-10-31

metyrapone and Pachymeningitis

metyrapone has been researched along with Pachymeningitis in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research Excerpts

ExcerptRelevanceReference
"Treatment with metyrapone decreased her cortisol production and produced clinical remission of Cushing's syndrome."1.25The immunological hazard of Cushing's syndrome. ( Britton, S; Sjoberg, HE; Thorén, M, 1975)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Britton, S1
Thorén, M1
Sjoberg, HE1
Hohenegger, M1

Other Studies

2 other studies available for metyrapone and Pachymeningitis

ArticleYear
The immunological hazard of Cushing's syndrome.
    British medical journal, 1975, Dec-20, Volume: 4, Issue:5998

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Cryptococcosis; Cushing Syndrome; Female; Fluorouracil; Hum

1975
[On the function of the anterior pituitary lobe in meningitis studies with the metopirone test].
    Endokrinologie, 1965, Volume: 48, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Humans; Meningitis; Metyrapone; Pituitary Gl

1965